NuCana (NCNA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NCNA NuCana

Watchlist

0.9400
+0.0099+1.06%

Close Feb 26 16:00 ET

0.9400
0.00000.00%

Post 20:01 ET

3.69MMarket Cap-0.06P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | NuCana PLC: Effective Feb 7, Donald Munoz Departed From His Role as CFO
ReutersFeb 10 08:18 ET
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
BusinesswireFeb 10 07:00 ET
European Equities Traded in the US as American Depositary Decline in Tuesday Trading
MT NewswiresNov 26, 2024 11:12 ET
Nucana Reports Third Quarter Loss Amid R&D Investments
TipRanksNov 25, 2024 08:23 ET
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
SECNov 25, 2024 07:52 ET · Announcements
NuCana Plc Reports Encouraging Clinical Data for NUC-7738 and NUC-3373, Highlights Financial Position and Future Milestones
Quiver QuantitativeNov 25, 2024 07:12 ET

Comments

rmgm

Feb 20 14:32

$NuCana (NCNA.US)$ Smart move from whoever is controlling this stock . Any day this closes above 1$ resets the 30 business day below 1$ NASDAQ rule for delisting risk . Way oversold stock though and 5 days green candles and MACD crossover on the daily . Need volume + news

Jaguar8

Dec 29, 2024 13:13

🟢 Watchlist December 30,2024, Monday.

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
7. I DO NOT give buy or sell advice
8. CH (cash on hand); AH (after hours): RTH (regular trading hours)
9. No buy pressure/momentum- No day trade.
10. Remember, some stocks may get pumped WITHOUT any catalyst this week ...

138

SteadyBoomBeepBeep

Nov 11, 2024 08:34

$NuCana (NCNA.US)$ squeeze it

DipHuntah_808

Nov 11, 2024 06:42

$NuCana (NCNA.US)$
550% CTB loading 1.5 too 1.6

Teddy123

Nov 11, 2024 06:41

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

$NuCana (NCNA.US)$
EDINBURGH, United Kingdom, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that initial data from the ongoing Phase 1b/2 modular study (NuTide:303) investigating NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors (Module 1) and in combination with docetaxel for patients with lun...

NCNA NuCana

Trade Overview

Capital Trend

News

Comments

Trending Stocks